These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8238014)

  • 1. The effect of treatment with recombinant human erythropoietin on skeletal muscle function in patients with end-stage renal failure treated with regular hospital hemodialysis.
    Davenport A
    Am J Kidney Dis; 1993 Nov; 22(5):685-90. PubMed ID: 8238014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nutritional assessment in anemic hemodialysis patients treated with recombinant human erythropoietin.
    Bárány P; Pettersson E; Ahlberg M; Hultman E; Bergström J
    Clin Nephrol; 1991 Jun; 35(6):270-9. PubMed ID: 1873941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of recombinant human erythropoietin on exercise capacity in hemodialysis patients.
    Painter P; Moore GE
    Adv Ren Replace Ther; 1994 Apr; 1(1):55-65. PubMed ID: 7641089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of nutritional status in patients receiving maintenance hemodialysis after correction of renal anemia with recombinant human erythropoietin.
    Tarng DC; Huang TP; Doong TI
    Nephron; 1998; 78(3):253-9. PubMed ID: 9546682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant erythropoietin improves exercise capacity in anemic hemodialysis patients.
    Robertson HT; Haley NR; Guthrie M; Cardenas D; Eschbach JW; Adamson JW
    Am J Kidney Dis; 1990 Apr; 15(4):325-32. PubMed ID: 2321645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of recombinant human erythropoietin treatment on left ventricular hypertrophy and cardiac function in dialysis patients.
    Massimetti C; Pontillo D; Feriozzi S; Costantini S; Capezzuto A; Ancarani E
    Blood Purif; 1998; 16(6):317-24. PubMed ID: 10343078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of erythropoietin on strength and functional status of patients on hemodialysis.
    Guthrie M; Cardenas D; Eschbach JW; Haley NR; Robertson HT; Evans RW
    Clin Nephrol; 1993 Feb; 39(2):97-102. PubMed ID: 8448925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost benefits of low dose subcutaneous erythropoietin in patients with anaemia of end stage renal disease.
    Stevens ME; Summerfield GP; Hall AA; Beck CA; Harding AJ; Cove-Smith JR; Paterson AD
    BMJ; 1992 Feb; 304(6825):474-7. PubMed ID: 1547417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of treatment with recombinant human erythropoietin on the histological appearance and glycogen content of skeletal muscle in patients with chronic renal failure treated by regular hospital haemodialysis.
    Davenport A; King RF; Ironside JW; Will EJ; Davison AM
    Nephron; 1993; 64(1):89-94. PubMed ID: 8502342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial.
    Eschbach JW; Egrie JC; Downing MR; Browne JK; Adamson JW
    N Engl J Med; 1987 Jan; 316(2):73-8. PubMed ID: 3537801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Does erythropoietin restrict lef ventricular hypertrophy in patients with chronic renal failure?].
    Switalski M; Boniecka Z; Gellert R
    Pol Arch Med Wewn; 2002 Apr; 107(4):389-92. PubMed ID: 12189932
    [No Abstract]   [Full Text] [Related]  

  • 12. Hemodynamic effects of partial correction of chronic anemia by recombinant human erythropoietin in patients on dialysis.
    Mayer G; Cada EM; Watzinger U; Barnas U; Graf H
    Am J Kidney Dis; 1991 Mar; 17(3):286-9. PubMed ID: 1996570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anemia and progression of renal failure].
    Gellert R
    Pol Arch Med Wewn; 2002 Apr; 107(4):375-7. PubMed ID: 12189930
    [No Abstract]   [Full Text] [Related]  

  • 14. The effects of recombinant human erythropoietin on mean corpuscular volume in patients with the anemia of chronic renal failure.
    Schwartz AB; Orquiza CS
    Clin Nephrol; 1995 Apr; 43(4):256-9. PubMed ID: 7606880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of anemia by erythropoietin therapy retards the progression of chronic renal failure, especially in nondiabetic patients.
    Kuriyama S; Tomonari H; Yoshida H; Hashimoto T; Kawaguchi Y; Sakai O
    Nephron; 1997; 77(2):176-85. PubMed ID: 9346384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The use of recombinant erythropoietin with patients on programmed hemodialysis].
    Rozental' RL; Zezina LIu; Spudass AV
    Ter Arkh; 1991; 63(12):110-3. PubMed ID: 1803587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recombinant human erythropoietin stimulates synthesis of fetal hemoglobin in patients with renal anemia treated by repeated hemodialysis].
    Hanicki Z; Sułowicz W; Stepniewski M; Kuźniewski M; Kraśniak A; Kopeć J; Cieszkowska U; Solarska K
    Pol Arch Med Wewn; 1991 Jun; 85(6):352-5. PubMed ID: 1716757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Echocardiographic findings in hemodialysis patients treated with recombinant human erythropoietin: proposal for a hematocrit most beneficial to hemodynamics.
    Tagawa H; Nagano M; Saito H; Umezu M; Yamakado M
    Clin Nephrol; 1991 Jan; 35(1):35-8. PubMed ID: 2007294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The efficacy of an erythropoietin-calcitriol combination in patients with chronic kidney failure on programmed hemodialysis].
    Nikolaev AIu; Klepikov PV; Lashutin SV; Kukhtevich AV
    Ter Arkh; 1995; 67(5):27-31. PubMed ID: 7638771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of hemodialysis and recombinant human erythropoietin on determinants of blood viscosity.
    Shand BI; Buttimore AL; Lynn KL; Bailey RR; Robson RA
    Ren Fail; 1994; 16(3):407-13. PubMed ID: 8059023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.